| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/05/2014 | EP2692355A1 Apolactoferrin for the treatment of iron accumulation diseases |
| 02/05/2014 | EP2692354A1 Means for treating heart disease |
| 02/05/2014 | EP2692353A2 Peptide LGD or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis |
| 02/05/2014 | EP2692352A1 Hot flash suppressant |
| 02/05/2014 | EP2692350A2 Lyophilized preparation of botulinum toxin |
| 02/05/2014 | EP2691549A1 Natural derivate of the lactobacillus johnsonii strain cncm 1-1225 deficient in d-lactic acid production |
| 02/05/2014 | EP2691422A2 Methods and compositions for cytomegalovirus il-10 protein |
| 02/05/2014 | EP2691370A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan |
| 02/05/2014 | EP2691369A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan |
| 02/05/2014 | EP2691120A2 Theranostic imaging agents and methods of use |
| 02/05/2014 | EP2691109A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 02/05/2014 | EP2691108A1 Novel glucagon analogues |
| 02/05/2014 | EP2691107A1 Methods for using semaphorin polypeptides |
| 02/05/2014 | EP2691106A2 Antiviral composition |
| 02/05/2014 | EP2691105A1 Methods and compositions related to inhibition of viral entry |
| 02/05/2014 | EP2691104A1 Ezatiostat for treating multiple myeloma |
| 02/05/2014 | EP2691103A1 Method for treating disorders of the skin |
| 02/05/2014 | CN103562381A Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life |
| 02/05/2014 | CN103562220A 抗癌融合蛋白 Anticancer fusion protein |
| 02/05/2014 | CN103561788A Method for inducing in vivo migration of stem cell |
| 02/05/2014 | CN103561761A Methods and compositions for improving antiangiogenic therapy with anti-integrins |
| 02/05/2014 | CN103561758A Method for inactivation/removal of coagulation factors by precipitation |
| 02/05/2014 | CN103561757A Freeze-dried preparation containing high-purity pth and method for producing same |
| 02/05/2014 | CN103561756A Composition for preventing and/or ameliorating cancer-related irreversible metabolism disorders |
| 02/05/2014 | CN103561589A Protein hydrolysate compositions having enhanced CCK and GLP-1 releasing activity |
| 02/05/2014 | CN103555760A Preparation method and preparation of recombinant human thrombopoietin |
| 02/05/2014 | CN103555729A Modified TRAIL gene sequence, expression method and application |
| 02/05/2014 | CN103555678A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2014 | CN103555677A A method of identifying unknown adeno-associated virus (avv) sequences and a kit for the metho |
| 02/05/2014 | CN103555676A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2014 | CN103555527A Snake peptide healthcare wine and preparation method thereof |
| 02/05/2014 | CN103554985A Repeatedly opened/closed molecule release system of dual-switch response control and preparation method and application |
| 02/05/2014 | CN103554269A Recombinant porcine follicle-stimulating hormone-Fc fusion protein (pFSH-Fc) |
| 02/05/2014 | CN103554268A Long-acting recombinant follicle-stimulating hormone and application thereof |
| 02/05/2014 | CN103554266A Tumstatin fusogenic peptide with anti-tumor effect, and preparation method and application thereof |
| 02/05/2014 | CN103554246A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 02/05/2014 | CN103554244A Active peptide inhibiting respiratory viral infection and application and preparation method thereof |
| 02/05/2014 | CN103554242A Liproteins, preparation method and application of liproteins in preparing medicament for preventing and treating tumor diseases |
| 02/05/2014 | CN103554232A Linear synthetic peptide G and antiviral application thereof |
| 02/05/2014 | CN103554225A Synthetic antibacterial peptides and application thereof |
| 02/05/2014 | CN103554222A Compounds for enzyme inhibition |
| 02/05/2014 | CN103554143A Derivatives of 1-amino-2-cyclobutylethylboronic acid |
| 02/05/2014 | CN103550784A Disease prevention and relief through human myoblast transplantation |
| 02/05/2014 | CN103550761A Cream for wound surface and preparation method thereof |
| 02/05/2014 | CN103550760A Application of lactoferrin in preparing medicine for treating anemia of adipose people with high inflammatory factors |
| 02/05/2014 | CN103550759A Gel agent for promoting wound healing of severe bedsore caused by diabetes |
| 02/05/2014 | CN103550758A Application of thymosin alpha 1 in preparing medicament for treating sarcoidosis |
| 02/05/2014 | CN103550757A Method for treating lung diseases by using interferon |
| 02/05/2014 | CN103550756A Paste for treating acne |
| 02/05/2014 | CN103550755A Florfenicol/colistin sulfate soluble powder and preparation method thereof |
| 02/05/2014 | CN103550259A Veterinary drug capable of increasing weight of broiler chickens |
| 02/05/2014 | CN103550227A Method for treating diabetes by combining traditional Chinese medicine and western medicine |
| 02/05/2014 | CN103550137A Controlled release formulations of octreotide |
| 02/05/2014 | CN102764426B Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof |
| 02/05/2014 | CN102757948B Haemocoagulase agkistrodon and separation method thereof |
| 02/05/2014 | CN102697811B Method for preparing transfer factors capable of resisting gosling plague virus |
| 02/05/2014 | CN102697808B In-vitro preparation method of transfer factors capable of resisting duck viral hepatitis |
| 02/05/2014 | CN102675424B Polypeptide drug for resisting Hepatitis B virus X protein |
| 02/05/2014 | CN102675423B Polypeptide medicine against hepatitis B virus X protein |
| 02/05/2014 | CN102675422B Polypeptide drug against hepatitis B virus X protein (HBx) |
| 02/05/2014 | CN102618612B Preparation method for black-bone chicken peptide for chemotherapy, attenuation and synergia and application of black-bone chicken peptide |
| 02/05/2014 | CN102268075B Glycopeptide drug-fast bacteria resisting antibiotic as well as preparation method and application thereof |
| 02/05/2014 | CN101928739B Preparation method of high-density lipoprotein and application thereof |
| 02/04/2014 | US8642757 High titer production of highly linear poly (α 1,3 glucan) |
| 02/04/2014 | US8642747 Genetic modification of targeted regions of the cardiac conduction system |
| 02/04/2014 | US8642745 Method for making multispecific antibodies having heteromultimeric and common components |
| 02/04/2014 | US8642739 Nuclear factor κB inducing factor |
| 02/04/2014 | US8642738 Modified vitamin K-dependent polypeptides |
| 02/04/2014 | US8642736 Casein complexes |
| 02/04/2014 | US8642735 Biologic replacement for fibrin clot |
| 02/04/2014 | US8642734 Method of producing polymers of spider silk proteins |
| 02/04/2014 | US8642733 T-cell stimulating protein B and methods of use |
| 02/04/2014 | US8642732 Polymer-conjugated glycosylated neublastin |
| 02/04/2014 | US8642731 Porphyromonas gingivalis polypeptides and nucleotides |
| 02/04/2014 | US8642728 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 02/04/2014 | US8642727 Selective glucagon-like-peptide-2 (GLP-2) analogues |
| 02/04/2014 | US8642726 Peptide epitopes of apolipoprotein B |
| 02/04/2014 | US8642725 Process for production of peptide thioester |
| 02/04/2014 | US8642724 Colon cancer related gene TOM34 |
| 02/04/2014 | US8642666 Biodegradable block copolymeric compositions for drug delivery |
| 02/04/2014 | US8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives |
| 02/04/2014 | US8642565 Increase of immune response and targeting by antigens and/or drug linkage |
| 02/04/2014 | US8642561 Peptides whose uptake by cells is controllable |
| 02/04/2014 | US8642560 Template fixed β-hairpin loop mimetics and their use in phage display |
| 02/04/2014 | US8642557 CTLA4 proteins and their uses |
| 02/04/2014 | US8642556 Methods of providing therapeutic effects using cyclosporin components |
| 02/04/2014 | US8642555 Prodrugs |
| 02/04/2014 | US8642554 Smac mimetic dimers and trimers useful as anti-cancer agents |
| 02/04/2014 | US8642553 Acacia macrostachya seed extract and compositions containing same |
| 02/04/2014 | US8642552 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 02/04/2014 | US8642551 Use of liver growth factor (LGF) as a neural tissue regenerator |
| 02/04/2014 | US8642550 Chimeric natriuretic peptides without hypotensive inducing capability |
| 02/04/2014 | US8642548 Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 02/04/2014 | US8642547 Methods for accelerating the healing of connective tissue injuries and disorders |
| 02/04/2014 | US8642546 FGF21 mutant fusion polypeptides and uses thereof |
| 02/04/2014 | US8642544 N-terminus conformationally constrained GLP-1 receptor agonist compounds |
| 02/04/2014 | US8642543 Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 02/04/2014 | US8642542 Recombinant fusion proteins to growth hormone and serum albumin |
| 02/04/2014 | US8642541 Glucagon analogues |
| 02/04/2014 | US8642540 Glucagon analogues |